SCHEMBL2167651

SCHEMBL2167651

O=C1C=CC(=C(c2ccccc2F)c2ccccc2F)O1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
ALDH1A1 P00352 4/20 0.42
ALOX15 P16050 2/20 0.42
GAA P10253 2/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
HPGD P15428 3/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 2/20 0.37
PTPN1 P18031 1/20 0.36
ERCC5 P28715 1/20 0.36
FEN1 P39748 1/20 0.36
LMNA P02545 1/20 0.35
RAB9A P51151 2/20 0.35
BCHE P06276 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2166868 0.72 ALDH1A1 (0.37) CES2CES1ALDH1A1ALOX15KMT2A
SCHEMBL2166261 0.69 HSP90AA1 (0.46) CES2CES1KMT2AMEN1MAPT
SCHEMBL16628800 0.67 SELL (0.44) ALDH1A1ALOX15GAAKMT2AMEN1
Phthalic Acid SCHEMBL3811685 0.66 ALDH1A1 (0.64) ALDH1A1ALOX15HPGDMAPTLMNA
SCHEMBL9888297 0.66 KMT2A (0.41) ALDH1A1ALOX15GAAKMT2AMEN1
SCHEMBL2166808 0.66 CES2 (0.47) CES2ALDH1A1ALOX15GAAKMT2A
SCHEMBL250099 0.64 CES2 (0.71) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL2156696 0.64 CES2 (1.00) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL30293901 0.64 CES2 (0.71) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL13429979 0.63 CES2 (0.45) CES2CES1ALDH1A1ALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350036-B1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO COSMÉTIQUE (FR) 2015-04-15 EP claimed
US-8563548-B2 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-10-22 US claimed
EP-2350036-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS Pierre Fabre Dermo-Cosmétique (FR) 2011-08-03 EP claimed
US-20110184059-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-07-28 US claimed
WO-2010034827-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-04-01 WO claimed
EP-2350036-B1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO COSMÉTIQUE (FR) 2015-04-15 EP disclosed
US-8563548-B2 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-10-22 US disclosed
US-8563548-B2 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-10-22 US disclosed
US-8563548-B2 Methylene furanone derivatives and use of said derivatives as a photoprotecting or antioxidant or depigmentation agent in cosmetic or dermatological compositions PIERRE FABRE DERMO-COSMETIQUE (FR) 2013-10-22 US disclosed
EP-2350036-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS Pierre Fabre Dermo-Cosmétique (FR) 2011-08-03 EP disclosed
US-20110184059-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-07-28 US disclosed
US-20110184059-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-07-28 US disclosed
US-20110184059-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-07-28 US disclosed
WO-2010034827-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS PIERRE FABRE DERMO-COSMETIQUE (FR) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184059-A1 METHYLENE FURANONE DERIVATIVES AND USE OF SAID DERIVATIVES AS A PHOTOPROTECTING OR ANTIOXIDANT OR DEPIGMENTATION AGENT IN COSMETIC OR DERMATOLOGICAL COMPOSITIONS NQO1, ESD, DHPS CES2 2351/4885CES1 2081/4885ALDH1A1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.